Savara
SVRA
#6219
Rank
ยฃ0.75 B
Marketcap
ยฃ3.69
Share price
-2.57%
Change (1 day)
21.16%
Change (1 year)

P/E ratio for Savara (SVRA)

P/E ratio as of November 2026 (TTM): -8.29

According to Savara's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -8.28814. At the end of 2022 the company had a P/E ratio of -6.20.

P/E ratio history for Savara from 2017 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-6.2070%
2021-3.65166.39%
2020-1.37-41.02%
2019-2.32-42.35%
2018-4.03-16.97%
2017-4.85

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
OPKO Health
OPK
-19.2 131.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0.9953-87.99%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.